Submit Deal

KRIYA THERAPEUTICS INC

HQ - Durham, North Carolina

Summary

A clinical-stage biotechnology company developing gene therapies for chronic diseases of high unmet need.

Deals Overview

Total Deals5

Valued Deals2

Total Value£ 293 M

Avg. Deal Size£ 146 M

Market Context

Senior Management

Shankar Ramaswamy
Founder and CEO
Neera Ravindran
CFO
Curt Herberts
CFO

Sort

14 Jul 2021|United States|Software

Target: KRIYA THERAPEUTICS INC

Bidder: WOODLINE PARTNERS

14 Service Providers

2 Target | 12 Bidder

14 Dealmakers

2 Target | 12 Bidder

£ 72 M

Value

07 Jan 2021|United States|Medical Services

Target: WARDEN BIO

Bidder: KRIYA THERAPEUTICS INC

4 Service Providers

1 Target | 3 Bidder

14 Dealmakers

1 Target | 13 Bidder

n/a

Value

16 May 2022|United States|Software

Target: KRIYA THERAPEUTICS INC

Bidder: NARYA CAPITAL

13 Service Providers

3 Target | 10 Bidder

13 Dealmakers

3 Target | 10 Bidder

£ 220 M

Value

16 Nov 2022|United States|Biotechnology

Target: REDPIN THERAPEUTICS

Bidder: KRIYA THERAPEUTICS INC

4 Service Providers

2 Target | 2 Bidder

15 Dealmakers

4 Target | 11 Bidder

n/a

Value

06 Sep 2023|Spain|Medical Services

Target: TRAMONTANE THERAPEUTICS

Bidder: KRIYA THERAPEUTICS INC

5 Service Providers

2 Target | 3 Bidder

4 Dealmakers

1 Target | 3 Bidder

n/a

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy